Business case to inform direction of Australian nuclear medicine
Consultant appointed to consider a variety of financial, manufacture and import options.
Showing 41 - 60 of 293 results
Consultant appointed to consider a variety of financial, manufacture and import options.
With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.
Participate in live radiation demonstrations, cover syllabus content and visit ANSTO virtually during our online depth study classes for Year 12 Investigating Science.
- Participate in live demonstrations of the properties of radiation, shielding and technologies used to detect radiation.
- Learn about the OPAL multipurpose reactor, the use of nuclear medicine and their impact on society.
- Discuss the public perception of nuclear science and the regulation of scientific research.
Cost: $90 per class.
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.
The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).
Participate in live radiation demonstrations, cover syllabus content and visit ANSTO virtually during our online depth study classes for Year 12 Physics.
- Participate in live demonstrations to review the properties of alpha, beta and gamma radiation.
- Learn about radioactive decay, half-life and methods of detecting radiation, including with a cloud chamber.
- Define and understand applications of fission, fusion, binding energy and mass defect, and investigate the structure and function of the OPAL multipurpose reactor.
- Investigate the role and operation of particle accelerators at ANSTO.
Cost: $90 per class.
Nuclear engineer, Robert Mardus-Hall, with his research partner Andrew Pastrello, are developing nuclear power based solutions for space missions to the Moon and Mars.
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
Applications, Recent results, Publications.
Radiation can be described as energy or particles from a source that travel through space or other mediums. Light, heat, and wireless communications are all forms of radiation.
The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.
Pamela Naidoo-Ameglio takes up executive role
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.